Article info

Download PDFPDF
Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer
  1. Address correspondence and reprint requests to Hans-Christian Bösmüller, MD, Institute of Pathology, University Hospital of Tübingen, Liebermeisterstraße 8, D-72076 Tübingen, Germany. E-mail: hans.boesmueller{at}med.uni-tuebingen.de.

Citation

Bösmüller H, Wagner P, Peper JK, et al
Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer

Publication history

  • Received October 19, 2015
  • Accepted January 3, 2016
  • First published May 1, 2016.
Online issue publication 
June 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.